Call Our
HELPLINE
1-800-4PD-INFO

National Parkinson Foundation's blog

What's Hot in PD? Everything a Parkinson’s Patient Needs to Know about Safinamide (Xadago): Should You Switch?

Date: 
Monday, April 3, 2017
Author: 
Dr. Michael S. Okun

Safinamide (Xadago) was approved by the Food and Drug Administration (FDA) for treatment of Parkinson’s disease (PD) medication fluctuations. Safinamide is a pill that when absorbed in the bloodstream travels to the brain and affects dopaminergic and non-dopaminergic systems.

Pages